The effects of bazedoxifene on mammographie breast density in postmenopausal women with osteoporosis

Menopause

Volumn 16, Issue 6, 2009, Pages 1193-1196

  Harvey, Jennifer A ^a   Holm, Mary K ^b   Ranganath, Radhika ^c   Guse, Paul A ^c   Trott, Edward A ^c   Helzner, Eileen ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Dakota Clinic   (United States)

^c PFIZER INC   (United States)

Author keywords

Bazedoxifene; Breast density; Mammography; Osteoporosis; SERMs

Indexed keywords

BAZEDOXIFENE; CALCIUM; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D; BONE DENSITY CONSERVATION AGENT; INDOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BONE DENSITY; BREAST; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DENSITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; POSTMENOPAUSE OSTEOPOROSIS; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; COMPARATIVE STUDY; MIDDLE AGED; POSTMENOPAUSE;

BONE DENSITY CONSERVATION AGENTS; BREAST; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; MAMMOGRAPHY; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PLACEBOS; POSTMENOPAUSE; RALOXIFENE; RETROSPECTIVE STUDIES; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 71249138285     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a7fb1e     Document Type: Article

References (25)

1. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographie detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-1087. (Pubitemid 30616482)
2. Byrne C. Invited commentary: assessing breast density change - lessons for future studies. Am J Epidemiol 2008;167:1037-1040. (Pubitemid 351601249)
3. Ursin G, Ma H, Wu AH, et al. Mammographie density and breast cancer in. three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003; 12: 332-338. (Pubitemid 36427994)
4. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159-1169.
5. Boyd NF, Rommens JM, Vogt K, et al. Mammographie breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6: 798-808. (Pubitemid 41430721)
6. Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographie density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587-1598. (Pubitemid 128467077)
7. Stamper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal density on mammograms in 1.353 women 25-79 years old. AJR Am J Roentgenol 1996;167:1261-1265.
8. Topal NB, Ayhan S, Topal U, Bilgin T. Effects of hormone replacement therapy regimens on mammographie breast density: the role of progestins. J Obstet Gynaecol Res 2006;32:305-308. (Pubitemid 43800423)
9. Santen R. Menopausal hormone therapies: their effect on mammographie density and breast cancer risk. Gynecol Endocrinol 2005;21:12-16. (Pubitemid 41345495)
10. Sterns EE, Zee B. Mammographie density changes in perimenopausal and postmenopausal, women: is effect of hormone replacement therapy predictable? Breast Cancer Res Treat 2000;59:125-132. (Pubitemid 30216135)
11. Harvey JA, Pinkerton JV, Herman CR. Short-term cessation of hormone replacement therapy and improvement of mammographie specificity. J Natl Cancer Inst 1997;89:1623-1625. (Pubitemid 27479724)
12. Kaewrudee S, Anuwutnavin S, Kanpittaya J, Soontrapa S, Sakondhavat C. Effect of estrogen-progestin and estrogen on. mammographie density. J Reprod Med 2007;52:513-520. (Pubitemid 46981872)
13. Harvey JA, Cowan JH III, LoRusso AP. Increase in mammographie breast density associated with the use of domperidone. Breast J 2004;10: 256-258.
14. Komm BS, Lyttle CR. Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation. Ann N Y Acad Sci 2001;949:317-326.
15. Atkinson C, Warren R, Bingham SA, Day NE. Mammographie patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999;8:863-866. (Pubitemid 29508720)
16. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J. Effect of tamoxifen on mammographie density. Cancer Epidemiol Biomarkers Prev 2000;9:917-921.
17. Freedman M, San Martin J, O'Gorman J, et al. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst 2001;93:51-56. (Pubitemid 32060890)
18. Lasco A, Gaudio A, Morini E, et al. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women. Menopause 2006;13:787-792. (Pubitemid 44435033)
19. Jackson VP, San Martin. JA, Secrest RJ, et al. Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographie breast density and breast tenderness in postmenopausal women. Am J Obstet Gynecol 2003;188:389-394. (Pubitemid 36249976)
20. Miller PD, Chines AA, Christiansen C, et al. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo, and active-controlled study. J Bone Miner Res 2008;23:525-535.
21. Silverman SL, Christiansen C, Genant HK, et al. Efficacy of bazedoxifene in reducing new vertebral, fracture risk in. postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo- and active-controlled, clinical trial. J Bone Miner Res 2008;23:1923-1934.
22. Harvey JA, Bovbjerg VE. Quantitative assessment of mammographie breast density: relationship with breast cancer risk. Radiology 2004;230: 29-41. (Pubitemid 37549780)
23. Harvey JA. Mammographie breast density: the imaging perspective. Menopausal Med 2005;13:8-12.
24. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographie densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-675.
25. Kelemen LE, Pankratz VS, Sellers TA, et al. Age-specific trends in mammographie density: the Minnesota Breast Cancer Family Study. Am J Epidemiol 2008;167:1027-1036.